Singhal Priya's Form 4 filing
Biogen Inc. (BIIB) · filed Feb 5, 2024
- Accession no.
- 0001127602-24-003440
- Filed
- Feb 5, 2024
- Trade date
- Feb 1-2, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $155.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Singhal PriyaCIK 0001769608 | Officer (Head of Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Common Stock | MOption exerciseAcquired | +1,828 | $0.00 | $0 | 5,292.09 | Direct | |
| Feb 1, 2024 | Common Stock | FTax withholdingDisposed | −561 | $247.83 | −$139,032.63 | 4,731.09 | Direct | |
| Feb 2, 2024 | Common Stock | SSaleDisposed | −634 | $245.93 | −$155,919.62 | 4,097.09 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Common Stock | MOption exerciseDisposed | −1,828 | $0.00 | $0 | 3,657 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.